technetium-99m (Tc-99m) is a radioactive isotope commonly used in nuclear medicine imaging procedures. One of the pharmaceutical forms of Tc-99m used for imaging is Tc-99m sulfur colloid. This radiopharmaceutical is used primarily for imaging the reticuloendothelial system, which includes the spleen, liver,and bone marrow.
Action:
Uptake and Localization: When administered to a patient, Tc-99m sulfur colloid is taken up by cells of the reticuloendothelial system, particularly macrophages. These cells are abundant in organs like the liver, spleen, and bone marrow.
Phagocytosis: The sulfur colloid particles are phagocytosed (engulfed) by macrophages. This phagocytic activity allows the radioactive tracer to concentrate in the reticuloendothelial cells of the organs of interest.
Imaging: The radioactive emissions from Tc-99m decay are used to create images through a gamma camera. The camera detects the gamma rays which is emitted by the Tc-99m atoms in the organs of interest, producing images that highlight the distribution and function of these organs.
Spectrum:
The spectrum of Tc-99m sulfur colloid refers to the varying energies of the gamma rays emitted during its decay. Tc-99m emits gamma rays during its decay process, and these gamma rays have specific energy levels characteristic of the isotope. The gamma rays are what the gamma camera detects to create the images.
The gamma rays emitted by Tc-99m have an energy level of approximately 140 keV (kilo-electron volts). This energy level is well-suited for medical imaging because it can penetrate tissues and is easily detectable by the gamma camera. The specific energy of 140 keV makes Tc-99m sulfur colloid a suitable radiopharmaceutical for imaging with gamma cameras commonly used in nuclear medicine.
DRUG INTERACTION
technetium Tc-99m sulfur colloid
&
technetium Tc-99m sulfur colloid +
No drug interaction found for technetium Tc-99m sulfur colloid and .
Frequency not defined
Confusion
Tightness in the chest
Itching
Fast heartbeat
Shortness of breath
Hives or welts
Cold, clammy skin
Fast, weak pulse
Dizziness
Sweating
Cough
Lightheadedness
Redness of the skin
Unusual tiredness or weakness
Difficulty swallowing
Wheezing
Black Box Warning:
None
Contraindication/Caution:
Contraindication
Allergic Reactions: Individuals with a history of severe allergic reactions to sulfur-containing compounds or other components of the radiopharmaceutical should not receive Tc-99m sulfur colloid. Allergic reactions can vary from mild skin rashes to more severe anaphylactic reactions.
Pregnancy and Breastfeeding: Tc-99m sulfur colloid should be avoided during pregnancy, especially in the 1st trimester, as radiation exposure to the developing fetus could pose a risk. The potential benefits and the risks should be discussed with a medical professional if a pregnant woman requires imaging. Similarly, breastfeeding mothers should consult their doctor before undergoing Tc-99m sulfur colloid imaging, as the radiopharmaceutical may be excreted in breast milk.
Hypersensitivity to Radiopharmaceuticals: Patients with a known hypersensitivity to radiopharmaceuticals or contrast agents may need to avoid Tc-99m sulfur colloid. It’s essential to inform the healthcare provider about any previous adverse reactions to such substances.
Acute Illness or Infection: Imaging procedures, including those using Tc-99m sulfur colloid, may be postponed if the patient is experiencing an acute illness or infection. In such cases, the imaging may not provide accurate results due to changes in organ function caused by the illness.
Interference with Other Medical Procedures: Tc-99m sulfur colloid imaging might interfere with specific medical procedures or treatments. Patients undergoing concurrent treatments or tests should consult their healthcare provider to determine the suitable timing and sequence of procedures.
Children and Adolescents: Special considerations may be necessary for children and adolescents. The potential risks and benefits of Tc-99m sulfur colloid imaging in this population should be carefully evaluated and discussed with a pediatric specialist.
Other Medical Conditions: Patients with certain medical conditions, such as severe liver disease or impaired liver function, may require specific precautions or adjustments in the imaging procedure. It’s crucial to provide your healthcare provider with a comprehensive medical history to ensure the procedure’s safety and effectiveness.
Caution
Radiation Exposure: Tc-99m sulfur colloid is a radioactive material, and patients and healthcare providers should be aware of potential radiation exposure. The radiation dose from this procedure is usually low and well within acceptable limits for diagnostic imaging, but precautions should still be taken, especially for pregnant or breastfeeding individuals.
Pregnancy and Breastfeeding: As mentioned earlier, pregnant women should avoid Tc-99m sulfur colloid imaging, especially during the 1st trimester, due to the potential risks of radiation exposure to the developing fetus.
Cumulative Radiation Exposure: Patients who have undergone multiple imaging procedures involving radiation should consider the cumulative effects of radiation exposure over time. Healthcare providers should be informed about recent imaging studies to ensure the cumulative radiation dose remains within safe limits.
Renal Impairment: Tc-99m sulfur colloid is primarily eliminated through the urinary system. Patients with severe renal impairment may experience delayed clearance of the radiopharmaceutical, which could affect the quality of the imaging results.
Drug Interactions: Certain medications, particularly those that affect the reticuloendothelial system or liver function, may potentially interfere with the distribution or uptake of Tc-99m sulfur colloid.
Allergic Reactions: Although severe allergic reactions to Tc-99m sulfur colloid are rare, patients with a history of allergies or hypersensitivity to radiopharmaceuticals or sulfur-containing compounds should be cautious. Any potential allergic reactions should be discussed with the healthcare provider before the procedure.
Delayed Imaging Results: In some cases, delayed imaging results can occur because of the factors such as slow clearance of the radiopharmaceutical from the body. This may affect the interpretation of the images, particularly if immediate or time-sensitive information is needed.
Pediatric and Geriatric Patients: Special caution should be exercised when administering Tc-99m sulfur colloid to pediatric or geriatric patients. Dosing adjustments and considerations for these populations may be necessary.
Pregnancy consideration:
US FDA pregnancy category: Not assigned.
Lactation:
Excreted into human milk: Yes.
Pregnancy category:
Category A: well-controlled and Satisfactory studies show no risk to the fetus in the first or later trimester.
Category B: there was no evidence of risk to the fetus in animal studies, and there were not enough studies on pregnant women.
Category C: there was evidence of risk of adverse effects in animal reproduction studies, and no adequate evidence in human studies must take care of potential risks in pregnant women.
Category D: adequate data with sufficient evidence of human fetal risk from various platforms, but despite the potential risk, and used only in emergency cases for potential benefits.
Category X:Drugs listed in this category outweigh the risks over benefits. Hence these categories of drugs need to be avoided by pregnant women.
Category N: There is no data available for the drug under this category.
Pharmacology:
technetium Tc-99m sulfur colloid is a radiopharmaceutical used in nuclear medicine imaging to assess the reticuloendothelial system. Upon intravenous administration, Tc-99m sulfur colloid particles are phagocytosed by macrophages in organs like the liver, spleen, and bone marrow.
The radioisotope Tc-99m emits gamma rays with an energy of approximately 140 keV, which is detected by gamma cameras or SPECT scanners to create images reflecting the distribution and function of these organs.
The imaging allows for evaluating liver and spleen morphology, bone marrow activity, gastrointestinal bleeding sources, and sentinel lymph node mapping, providing valuable diagnostic information for various medical conditions.
Pharmacodynamics:
Mechanism of action: The action of technetium Tc-99m sulfur colloid is primarily related to its use as a radiopharmaceutical for nuclear medicine imaging. It is not a therapeutic agent but rather a tracer that allows healthcare professionals to visualize specific organs and tissues in the body.
Injection and Distribution: Tc-99m sulfur colloid is administered to the patient through an intravenous injection. Once in the bloodstream, the radiopharmaceutical is rapidly distributed throughout the body.
Phagocytosis by Reticuloendothelial Cells: Tc-99m sulfur colloid particles are phagocytosed (engulfed) by specialized cells of the reticuloendothelial system. These cells, primarily macrophages, are found in organs like the liver, spleen, and bone marrow.
Accumulation in Target Organs: The macrophages concentrate Tc-99m sulfur colloid particles in the organs they populate. This accumulation reflects the natural function of the reticuloendothelial system in clearing cellular debris, pathogens, and other substances from the bloodstream.
Gamma Emission and Imaging: technetium-99m, a radioactive isotope, undergoes radioactive decay by emitting gamma rays with an energy of approximately 140 keV. These gamma rays can penetrate tissues and are detected by gamma cameras or single-photon emission computed tomography (SPECT) scanners.
Image Creation and Interpretation: The gamma camera or SPECT scanner captures the emitted gamma rays from the concentrated Tc-99m sulfur colloid in the organs of interest (e.g., liver, spleen). These emissions create detailed images highlighting the targeted organs’ distribution, size, shape, and function.
Pharmacokinetics:
Absorption
Tc-99m sulfur colloid is administered intravenously, typically as an injection into a vein. The radiopharmaceutical enters the bloodstream upon injection and is rapidly distributed throughout the body.
Distribution
Tc-99m sulfur colloid particles are taken up by cells of the reticuloendothelial system, primarily macrophages. These cells are abundant in organs such as the spleen, liver, and bone marrow. The particles are phagocytosed (engulfed) by the macrophages, leading to the concentration of the radiopharmaceutical in these organs. The Tc-99m sulfur colloid distribution in the reticuloendothelial system allows imaging of these organs’ morphology and function.
Metabolism
Tc-99m sulfur colloid undergoes minimal metabolism within the body. It remains particulate mainly and is processed by the reticuloendothelial cells. The radiopharmaceutical’s primary role is to serve as a tracer for imaging purposes, and its metabolic fate is not a significant focus of its use.
Elimination and Excretion
Tc-99m sulfur colloid is primarily eliminated from the body through the hepatobiliary system, which involves excretion through the liver and bile into the small intestine. A portion of the radiopharmaceutical may also be excreted through the urinary system. The excretion process helps to remove the radiopharmaceutical from the body over time.
Administration:
The technetium Tc-99m sulfur colloid administration involves several steps to ensure proper imaging of the reticuloendothelial system (liver, spleen, and bone marrow). It’s important to note that the specific procedure may vary based on the imaging facility, the patient’s condition, and the equipment available.
Patient Preparation:
Before the procedure, inform the patient about the imaging process, its purpose, and any potential risks or discomfort.
Obtain a detailed medical history, including allergies, medications, and previous imaging studies.
Informed Consent:
Obtain informed consent from the patient, explaining the procedure, its purpose, potential risks, and benefits. Ensure the patient has an opportunity to ask questions and fully understands the process.
Fasting:
Depending on the imaging protocol and the organs of interest, the patient may be instructed to fast for a certain period before the procedure. Fasting helps enhance imaging quality by reducing interference from food in the digestive system.
Radiopharmaceutical Injection:
A radiopharmaceutical technologist or nurse will administer the Tc-99m sulfur colloid via intravenous (IV) injection. The radioactive tracer is introduced into the bloodstream.
The dosage is calculated depend on the patient’s weight, the specific imaging protocol, and the desired imaging quality.
Patient Resting Period:
After the injection, the patient is typically asked to rest quietly. This allows the radiopharmaceutical to circulate and accumulate in the reticuloendothelial system.
Imaging Procedure:
The patient is then positioned for imaging. Depending on the organs being studied (liver, spleen, bone marrow), the imaging equipment (gamma camera or SPECT scanner) will be positioned accordingly.
The imaging procedure involves the patient lying still on a table while the gamma camera or SPECT scanner captures images of the radiopharmaceutical distribution in the body.
Image Acquisition:
The imaging process may take some time, and the patient is asked to remain as still as possible. Multiple images are usually taken from different angles to create a comprehensive view.
Post-Imaging Care:
Once the imaging is complete, the patient can resume normal activities unless instructed otherwise by the healthcare provider.
Drinking fluids and emptying the bladder may help eliminate any remaining traces of the radiopharmaceutical from the body.
Image Interpretation:
A nuclear medicine physician will review and interpret the acquired images to assess the distribution and function of the reticuloendothelial system.
technetium Tc-99m sulfur colloid is a radiopharmaceutical commonly used in nuclear medicine imaging to visualize and assess the reticuloendothelial system. This system includes the liver, spleen, and bone marrow. Tc-99m sulfur colloid is administered intravenously, and its distribution in these organs is captured using gamma cameras or SPECT scanners.
Liver Imaging:
Tc-99m sulfur colloid can provide valuable information about the liver’s size, shape, and function. It is used to diagnose and monitor various liver conditions, including cirrhosis, hepatic lesions, and tumors. The distribution pattern of the radiopharmaceutical can help identify abnormalities within the liver.
Spleen Imaging:
Spleen imaging with Tc-99m sulfur colloid assesses spleen size, function, and blood flow. It can aid in diagnosing conditions such as splenomegaly (enlarged spleen), hypersplenism, and various spleen disorders.
Bone Marrow Imaging:
Tc-99m sulfur colloid can visualize bone marrow activity and distribution. It is beneficial in suspected bone marrow disorders, such as myeloproliferative disorders, bone marrow metastases, and certain hematologic malignancies.
Gastrointestinal Bleeding Detection:
Tc-99m sulfur colloid imaging can help locate the source of gastrointestinal bleeding. It is beneficial when bleeding is suspected but cannot be easily identified through other imaging techniques.
Sentinel Lymph Node Mapping:
In some instances of cancer, particularly breast cancer and melanoma, Tc-99m sulfur colloid can be used to identify sentinel lymph nodes. These are the first lymph nodes to which cancer cells are likely to spread. Mapping sentinel lymph nodes can help guide surgical decisions and staging.
Peritoneal Scintigraphy:
Tc-99m sulfur colloid can be used in peritoneal scintigraphy to assess fluid movement within the abdominal cavity. It may help diagnose conditions like peritoneal leaks or assess the effectiveness of peritoneal dialysis.
Reticuloendothelial System Function Evaluation:
Tc-99m sulfur colloid imaging can provide insights into the overall function of the reticuloendothelial system, a key role in immune responses and the removal of cellular debris.
Contents are combined with the technetium Tc 99m sodium pertechnetate
Injection (Kit)
Contents are combined with the technetium Tc 99m sodium pertechnetate
Refer to adult dosing
DRUG INTERACTION
technetium Tc-99m sulfur colloid
&
technetium Tc-99m sulfur colloid +
No Drug Intearction Found. for technetium Tc-99m sulfur colloid and .
Actions and Spectrum:
technetium-99m (Tc-99m) is a radioactive isotope commonly used in nuclear medicine imaging procedures. One of the pharmaceutical forms of Tc-99m used for imaging is Tc-99m sulfur colloid. This radiopharmaceutical is used primarily for imaging the reticuloendothelial system, which includes the spleen, liver,and bone marrow.
Action:
Uptake and Localization: When administered to a patient, Tc-99m sulfur colloid is taken up by cells of the reticuloendothelial system, particularly macrophages. These cells are abundant in organs like the liver, spleen, and bone marrow.
Phagocytosis: The sulfur colloid particles are phagocytosed (engulfed) by macrophages. This phagocytic activity allows the radioactive tracer to concentrate in the reticuloendothelial cells of the organs of interest.
Imaging: The radioactive emissions from Tc-99m decay are used to create images through a gamma camera. The camera detects the gamma rays which is emitted by the Tc-99m atoms in the organs of interest, producing images that highlight the distribution and function of these organs.
Spectrum:
The spectrum of Tc-99m sulfur colloid refers to the varying energies of the gamma rays emitted during its decay. Tc-99m emits gamma rays during its decay process, and these gamma rays have specific energy levels characteristic of the isotope. The gamma rays are what the gamma camera detects to create the images.
The gamma rays emitted by Tc-99m have an energy level of approximately 140 keV (kilo-electron volts). This energy level is well-suited for medical imaging because it can penetrate tissues and is easily detectable by the gamma camera. The specific energy of 140 keV makes Tc-99m sulfur colloid a suitable radiopharmaceutical for imaging with gamma cameras commonly used in nuclear medicine.
Frequency not defined
Confusion
Tightness in the chest
Itching
Fast heartbeat
Shortness of breath
Hives or welts
Cold, clammy skin
Fast, weak pulse
Dizziness
Sweating
Cough
Lightheadedness
Redness of the skin
Unusual tiredness or weakness
Difficulty swallowing
Wheezing
Black Box Warning:
None
Contraindication/Caution:
Contraindication
Allergic Reactions: Individuals with a history of severe allergic reactions to sulfur-containing compounds or other components of the radiopharmaceutical should not receive Tc-99m sulfur colloid. Allergic reactions can vary from mild skin rashes to more severe anaphylactic reactions.
Pregnancy and Breastfeeding: Tc-99m sulfur colloid should be avoided during pregnancy, especially in the 1st trimester, as radiation exposure to the developing fetus could pose a risk. The potential benefits and the risks should be discussed with a medical professional if a pregnant woman requires imaging. Similarly, breastfeeding mothers should consult their doctor before undergoing Tc-99m sulfur colloid imaging, as the radiopharmaceutical may be excreted in breast milk.
Hypersensitivity to Radiopharmaceuticals: Patients with a known hypersensitivity to radiopharmaceuticals or contrast agents may need to avoid Tc-99m sulfur colloid. It’s essential to inform the healthcare provider about any previous adverse reactions to such substances.
Acute Illness or Infection: Imaging procedures, including those using Tc-99m sulfur colloid, may be postponed if the patient is experiencing an acute illness or infection. In such cases, the imaging may not provide accurate results due to changes in organ function caused by the illness.
Interference with Other Medical Procedures: Tc-99m sulfur colloid imaging might interfere with specific medical procedures or treatments. Patients undergoing concurrent treatments or tests should consult their healthcare provider to determine the suitable timing and sequence of procedures.
Children and Adolescents: Special considerations may be necessary for children and adolescents. The potential risks and benefits of Tc-99m sulfur colloid imaging in this population should be carefully evaluated and discussed with a pediatric specialist.
Other Medical Conditions: Patients with certain medical conditions, such as severe liver disease or impaired liver function, may require specific precautions or adjustments in the imaging procedure. It’s crucial to provide your healthcare provider with a comprehensive medical history to ensure the procedure’s safety and effectiveness.
Caution
Radiation Exposure: Tc-99m sulfur colloid is a radioactive material, and patients and healthcare providers should be aware of potential radiation exposure. The radiation dose from this procedure is usually low and well within acceptable limits for diagnostic imaging, but precautions should still be taken, especially for pregnant or breastfeeding individuals.
Pregnancy and Breastfeeding: As mentioned earlier, pregnant women should avoid Tc-99m sulfur colloid imaging, especially during the 1st trimester, due to the potential risks of radiation exposure to the developing fetus.
Cumulative Radiation Exposure: Patients who have undergone multiple imaging procedures involving radiation should consider the cumulative effects of radiation exposure over time. Healthcare providers should be informed about recent imaging studies to ensure the cumulative radiation dose remains within safe limits.
Renal Impairment: Tc-99m sulfur colloid is primarily eliminated through the urinary system. Patients with severe renal impairment may experience delayed clearance of the radiopharmaceutical, which could affect the quality of the imaging results.
Drug Interactions: Certain medications, particularly those that affect the reticuloendothelial system or liver function, may potentially interfere with the distribution or uptake of Tc-99m sulfur colloid.
Allergic Reactions: Although severe allergic reactions to Tc-99m sulfur colloid are rare, patients with a history of allergies or hypersensitivity to radiopharmaceuticals or sulfur-containing compounds should be cautious. Any potential allergic reactions should be discussed with the healthcare provider before the procedure.
Delayed Imaging Results: In some cases, delayed imaging results can occur because of the factors such as slow clearance of the radiopharmaceutical from the body. This may affect the interpretation of the images, particularly if immediate or time-sensitive information is needed.
Pediatric and Geriatric Patients: Special caution should be exercised when administering Tc-99m sulfur colloid to pediatric or geriatric patients. Dosing adjustments and considerations for these populations may be necessary.
Pregnancy consideration:
US FDA pregnancy category: Not assigned.
Lactation:
Excreted into human milk: Yes.
Pregnancy category:
Category A: well-controlled and Satisfactory studies show no risk to the fetus in the first or later trimester.
Category B: there was no evidence of risk to the fetus in animal studies, and there were not enough studies on pregnant women.
Category C: there was evidence of risk of adverse effects in animal reproduction studies, and no adequate evidence in human studies must take care of potential risks in pregnant women.
Category D: adequate data with sufficient evidence of human fetal risk from various platforms, but despite the potential risk, and used only in emergency cases for potential benefits.
Category X:Drugs listed in this category outweigh the risks over benefits. Hence these categories of drugs need to be avoided by pregnant women.
Category N: There is no data available for the drug under this category.
Pharmacology:
technetium Tc-99m sulfur colloid is a radiopharmaceutical used in nuclear medicine imaging to assess the reticuloendothelial system. Upon intravenous administration, Tc-99m sulfur colloid particles are phagocytosed by macrophages in organs like the liver, spleen, and bone marrow.
The radioisotope Tc-99m emits gamma rays with an energy of approximately 140 keV, which is detected by gamma cameras or SPECT scanners to create images reflecting the distribution and function of these organs.
The imaging allows for evaluating liver and spleen morphology, bone marrow activity, gastrointestinal bleeding sources, and sentinel lymph node mapping, providing valuable diagnostic information for various medical conditions.
Pharmacodynamics:
Mechanism of action: The action of technetium Tc-99m sulfur colloid is primarily related to its use as a radiopharmaceutical for nuclear medicine imaging. It is not a therapeutic agent but rather a tracer that allows healthcare professionals to visualize specific organs and tissues in the body.
Injection and Distribution: Tc-99m sulfur colloid is administered to the patient through an intravenous injection. Once in the bloodstream, the radiopharmaceutical is rapidly distributed throughout the body.
Phagocytosis by Reticuloendothelial Cells: Tc-99m sulfur colloid particles are phagocytosed (engulfed) by specialized cells of the reticuloendothelial system. These cells, primarily macrophages, are found in organs like the liver, spleen, and bone marrow.
Accumulation in Target Organs: The macrophages concentrate Tc-99m sulfur colloid particles in the organs they populate. This accumulation reflects the natural function of the reticuloendothelial system in clearing cellular debris, pathogens, and other substances from the bloodstream.
Gamma Emission and Imaging: technetium-99m, a radioactive isotope, undergoes radioactive decay by emitting gamma rays with an energy of approximately 140 keV. These gamma rays can penetrate tissues and are detected by gamma cameras or single-photon emission computed tomography (SPECT) scanners.
Image Creation and Interpretation: The gamma camera or SPECT scanner captures the emitted gamma rays from the concentrated Tc-99m sulfur colloid in the organs of interest (e.g., liver, spleen). These emissions create detailed images highlighting the targeted organs’ distribution, size, shape, and function.
Pharmacokinetics:
Absorption
Tc-99m sulfur colloid is administered intravenously, typically as an injection into a vein. The radiopharmaceutical enters the bloodstream upon injection and is rapidly distributed throughout the body.
Distribution
Tc-99m sulfur colloid particles are taken up by cells of the reticuloendothelial system, primarily macrophages. These cells are abundant in organs such as the spleen, liver, and bone marrow. The particles are phagocytosed (engulfed) by the macrophages, leading to the concentration of the radiopharmaceutical in these organs. The Tc-99m sulfur colloid distribution in the reticuloendothelial system allows imaging of these organs’ morphology and function.
Metabolism
Tc-99m sulfur colloid undergoes minimal metabolism within the body. It remains particulate mainly and is processed by the reticuloendothelial cells. The radiopharmaceutical’s primary role is to serve as a tracer for imaging purposes, and its metabolic fate is not a significant focus of its use.
Elimination and Excretion
Tc-99m sulfur colloid is primarily eliminated from the body through the hepatobiliary system, which involves excretion through the liver and bile into the small intestine. A portion of the radiopharmaceutical may also be excreted through the urinary system. The excretion process helps to remove the radiopharmaceutical from the body over time.
Administration:
The technetium Tc-99m sulfur colloid administration involves several steps to ensure proper imaging of the reticuloendothelial system (liver, spleen, and bone marrow). It’s important to note that the specific procedure may vary based on the imaging facility, the patient’s condition, and the equipment available.
Patient Preparation:
Before the procedure, inform the patient about the imaging process, its purpose, and any potential risks or discomfort.
Obtain a detailed medical history, including allergies, medications, and previous imaging studies.
Informed Consent:
Obtain informed consent from the patient, explaining the procedure, its purpose, potential risks, and benefits. Ensure the patient has an opportunity to ask questions and fully understands the process.
Fasting:
Depending on the imaging protocol and the organs of interest, the patient may be instructed to fast for a certain period before the procedure. Fasting helps enhance imaging quality by reducing interference from food in the digestive system.
Radiopharmaceutical Injection:
A radiopharmaceutical technologist or nurse will administer the Tc-99m sulfur colloid via intravenous (IV) injection. The radioactive tracer is introduced into the bloodstream.
The dosage is calculated depend on the patient’s weight, the specific imaging protocol, and the desired imaging quality.
Patient Resting Period:
After the injection, the patient is typically asked to rest quietly. This allows the radiopharmaceutical to circulate and accumulate in the reticuloendothelial system.
Imaging Procedure:
The patient is then positioned for imaging. Depending on the organs being studied (liver, spleen, bone marrow), the imaging equipment (gamma camera or SPECT scanner) will be positioned accordingly.
The imaging procedure involves the patient lying still on a table while the gamma camera or SPECT scanner captures images of the radiopharmaceutical distribution in the body.
Image Acquisition:
The imaging process may take some time, and the patient is asked to remain as still as possible. Multiple images are usually taken from different angles to create a comprehensive view.
Post-Imaging Care:
Once the imaging is complete, the patient can resume normal activities unless instructed otherwise by the healthcare provider.
Drinking fluids and emptying the bladder may help eliminate any remaining traces of the radiopharmaceutical from the body.
Image Interpretation:
A nuclear medicine physician will review and interpret the acquired images to assess the distribution and function of the reticuloendothelial system.
technetium Tc-99m sulfur colloid is a radiopharmaceutical commonly used in nuclear medicine imaging to visualize and assess the reticuloendothelial system. This system includes the liver, spleen, and bone marrow. Tc-99m sulfur colloid is administered intravenously, and its distribution in these organs is captured using gamma cameras or SPECT scanners.
Liver Imaging:
Tc-99m sulfur colloid can provide valuable information about the liver’s size, shape, and function. It is used to diagnose and monitor various liver conditions, including cirrhosis, hepatic lesions, and tumors. The distribution pattern of the radiopharmaceutical can help identify abnormalities within the liver.
Spleen Imaging:
Spleen imaging with Tc-99m sulfur colloid assesses spleen size, function, and blood flow. It can aid in diagnosing conditions such as splenomegaly (enlarged spleen), hypersplenism, and various spleen disorders.
Bone Marrow Imaging:
Tc-99m sulfur colloid can visualize bone marrow activity and distribution. It is beneficial in suspected bone marrow disorders, such as myeloproliferative disorders, bone marrow metastases, and certain hematologic malignancies.
Gastrointestinal Bleeding Detection:
Tc-99m sulfur colloid imaging can help locate the source of gastrointestinal bleeding. It is beneficial when bleeding is suspected but cannot be easily identified through other imaging techniques.
Sentinel Lymph Node Mapping:
In some instances of cancer, particularly breast cancer and melanoma, Tc-99m sulfur colloid can be used to identify sentinel lymph nodes. These are the first lymph nodes to which cancer cells are likely to spread. Mapping sentinel lymph nodes can help guide surgical decisions and staging.
Peritoneal Scintigraphy:
Tc-99m sulfur colloid can be used in peritoneal scintigraphy to assess fluid movement within the abdominal cavity. It may help diagnose conditions like peritoneal leaks or assess the effectiveness of peritoneal dialysis.
Reticuloendothelial System Function Evaluation:
Tc-99m sulfur colloid imaging can provide insights into the overall function of the reticuloendothelial system, a key role in immune responses and the removal of cellular debris.
technetium-99m (Tc-99m) is a radioactive isotope commonly used in nuclear medicine imaging procedures. One of the pharmaceutical forms of Tc-99m used for imaging is Tc-99m sulfur colloid. This radiopharmaceutical is used primarily for imaging the reticuloendothelial system, which includes the spleen, liver,and bone marrow.
Action:
Uptake and Localization: When administered to a patient, Tc-99m sulfur colloid is taken up by cells of the reticuloendothelial system, particularly macrophages. These cells are abundant in organs like the liver, spleen, and bone marrow.
Phagocytosis: The sulfur colloid particles are phagocytosed (engulfed) by macrophages. This phagocytic activity allows the radioactive tracer to concentrate in the reticuloendothelial cells of the organs of interest.
Imaging: The radioactive emissions from Tc-99m decay are used to create images through a gamma camera. The camera detects the gamma rays which is emitted by the Tc-99m atoms in the organs of interest, producing images that highlight the distribution and function of these organs.
Spectrum:
The spectrum of Tc-99m sulfur colloid refers to the varying energies of the gamma rays emitted during its decay. Tc-99m emits gamma rays during its decay process, and these gamma rays have specific energy levels characteristic of the isotope. The gamma rays are what the gamma camera detects to create the images.
The gamma rays emitted by Tc-99m have an energy level of approximately 140 keV (kilo-electron volts). This energy level is well-suited for medical imaging because it can penetrate tissues and is easily detectable by the gamma camera. The specific energy of 140 keV makes Tc-99m sulfur colloid a suitable radiopharmaceutical for imaging with gamma cameras commonly used in nuclear medicine.
Dosing & Uses
Drug Interaction
Adverse Reaction
Frequency not defined
Confusion
Tightness in the chest
Itching
Fast heartbeat
Shortness of breath
Hives or welts
Cold, clammy skin
Fast, weak pulse
Dizziness
Sweating
Cough
Lightheadedness
Redness of the skin
Unusual tiredness or weakness
Difficulty swallowing
Wheezing
Black Box Warning
Black Box Warning:
None
Contraindication / Caution
Contraindication/Caution:
Contraindication
Allergic Reactions: Individuals with a history of severe allergic reactions to sulfur-containing compounds or other components of the radiopharmaceutical should not receive Tc-99m sulfur colloid. Allergic reactions can vary from mild skin rashes to more severe anaphylactic reactions.
Pregnancy and Breastfeeding: Tc-99m sulfur colloid should be avoided during pregnancy, especially in the 1st trimester, as radiation exposure to the developing fetus could pose a risk. The potential benefits and the risks should be discussed with a medical professional if a pregnant woman requires imaging. Similarly, breastfeeding mothers should consult their doctor before undergoing Tc-99m sulfur colloid imaging, as the radiopharmaceutical may be excreted in breast milk.
Hypersensitivity to Radiopharmaceuticals: Patients with a known hypersensitivity to radiopharmaceuticals or contrast agents may need to avoid Tc-99m sulfur colloid. It’s essential to inform the healthcare provider about any previous adverse reactions to such substances.
Acute Illness or Infection: Imaging procedures, including those using Tc-99m sulfur colloid, may be postponed if the patient is experiencing an acute illness or infection. In such cases, the imaging may not provide accurate results due to changes in organ function caused by the illness.
Interference with Other Medical Procedures: Tc-99m sulfur colloid imaging might interfere with specific medical procedures or treatments. Patients undergoing concurrent treatments or tests should consult their healthcare provider to determine the suitable timing and sequence of procedures.
Children and Adolescents: Special considerations may be necessary for children and adolescents. The potential risks and benefits of Tc-99m sulfur colloid imaging in this population should be carefully evaluated and discussed with a pediatric specialist.
Other Medical Conditions: Patients with certain medical conditions, such as severe liver disease or impaired liver function, may require specific precautions or adjustments in the imaging procedure. It’s crucial to provide your healthcare provider with a comprehensive medical history to ensure the procedure’s safety and effectiveness.
Caution
Radiation Exposure: Tc-99m sulfur colloid is a radioactive material, and patients and healthcare providers should be aware of potential radiation exposure. The radiation dose from this procedure is usually low and well within acceptable limits for diagnostic imaging, but precautions should still be taken, especially for pregnant or breastfeeding individuals.
Pregnancy and Breastfeeding: As mentioned earlier, pregnant women should avoid Tc-99m sulfur colloid imaging, especially during the 1st trimester, due to the potential risks of radiation exposure to the developing fetus.
Cumulative Radiation Exposure: Patients who have undergone multiple imaging procedures involving radiation should consider the cumulative effects of radiation exposure over time. Healthcare providers should be informed about recent imaging studies to ensure the cumulative radiation dose remains within safe limits.
Renal Impairment: Tc-99m sulfur colloid is primarily eliminated through the urinary system. Patients with severe renal impairment may experience delayed clearance of the radiopharmaceutical, which could affect the quality of the imaging results.
Drug Interactions: Certain medications, particularly those that affect the reticuloendothelial system or liver function, may potentially interfere with the distribution or uptake of Tc-99m sulfur colloid.
Allergic Reactions: Although severe allergic reactions to Tc-99m sulfur colloid are rare, patients with a history of allergies or hypersensitivity to radiopharmaceuticals or sulfur-containing compounds should be cautious. Any potential allergic reactions should be discussed with the healthcare provider before the procedure.
Delayed Imaging Results: In some cases, delayed imaging results can occur because of the factors such as slow clearance of the radiopharmaceutical from the body. This may affect the interpretation of the images, particularly if immediate or time-sensitive information is needed.
Pediatric and Geriatric Patients: Special caution should be exercised when administering Tc-99m sulfur colloid to pediatric or geriatric patients. Dosing adjustments and considerations for these populations may be necessary.
Pregnancy / Lactation
Pregnancy consideration:
US FDA pregnancy category: Not assigned.
Lactation:
Excreted into human milk: Yes.
Pregnancy category:
Category A: well-controlled and Satisfactory studies show no risk to the fetus in the first or later trimester.
Category B: there was no evidence of risk to the fetus in animal studies, and there were not enough studies on pregnant women.
Category C: there was evidence of risk of adverse effects in animal reproduction studies, and no adequate evidence in human studies must take care of potential risks in pregnant women.
Category D: adequate data with sufficient evidence of human fetal risk from various platforms, but despite the potential risk, and used only in emergency cases for potential benefits.
Category X:Drugs listed in this category outweigh the risks over benefits. Hence these categories of drugs need to be avoided by pregnant women.
Category N: There is no data available for the drug under this category.
Pharmacology
Pharmacology:
technetium Tc-99m sulfur colloid is a radiopharmaceutical used in nuclear medicine imaging to assess the reticuloendothelial system. Upon intravenous administration, Tc-99m sulfur colloid particles are phagocytosed by macrophages in organs like the liver, spleen, and bone marrow.
The radioisotope Tc-99m emits gamma rays with an energy of approximately 140 keV, which is detected by gamma cameras or SPECT scanners to create images reflecting the distribution and function of these organs.
The imaging allows for evaluating liver and spleen morphology, bone marrow activity, gastrointestinal bleeding sources, and sentinel lymph node mapping, providing valuable diagnostic information for various medical conditions.
Pharmacodynamics:
Mechanism of action: The action of technetium Tc-99m sulfur colloid is primarily related to its use as a radiopharmaceutical for nuclear medicine imaging. It is not a therapeutic agent but rather a tracer that allows healthcare professionals to visualize specific organs and tissues in the body.
Injection and Distribution: Tc-99m sulfur colloid is administered to the patient through an intravenous injection. Once in the bloodstream, the radiopharmaceutical is rapidly distributed throughout the body.
Phagocytosis by Reticuloendothelial Cells: Tc-99m sulfur colloid particles are phagocytosed (engulfed) by specialized cells of the reticuloendothelial system. These cells, primarily macrophages, are found in organs like the liver, spleen, and bone marrow.
Accumulation in Target Organs: The macrophages concentrate Tc-99m sulfur colloid particles in the organs they populate. This accumulation reflects the natural function of the reticuloendothelial system in clearing cellular debris, pathogens, and other substances from the bloodstream.
Gamma Emission and Imaging: technetium-99m, a radioactive isotope, undergoes radioactive decay by emitting gamma rays with an energy of approximately 140 keV. These gamma rays can penetrate tissues and are detected by gamma cameras or single-photon emission computed tomography (SPECT) scanners.
Image Creation and Interpretation: The gamma camera or SPECT scanner captures the emitted gamma rays from the concentrated Tc-99m sulfur colloid in the organs of interest (e.g., liver, spleen). These emissions create detailed images highlighting the targeted organs’ distribution, size, shape, and function.
Pharmacokinetics:
Absorption
Tc-99m sulfur colloid is administered intravenously, typically as an injection into a vein. The radiopharmaceutical enters the bloodstream upon injection and is rapidly distributed throughout the body.
Distribution
Tc-99m sulfur colloid particles are taken up by cells of the reticuloendothelial system, primarily macrophages. These cells are abundant in organs such as the spleen, liver, and bone marrow. The particles are phagocytosed (engulfed) by the macrophages, leading to the concentration of the radiopharmaceutical in these organs. The Tc-99m sulfur colloid distribution in the reticuloendothelial system allows imaging of these organs’ morphology and function.
Metabolism
Tc-99m sulfur colloid undergoes minimal metabolism within the body. It remains particulate mainly and is processed by the reticuloendothelial cells. The radiopharmaceutical’s primary role is to serve as a tracer for imaging purposes, and its metabolic fate is not a significant focus of its use.
Elimination and Excretion
Tc-99m sulfur colloid is primarily eliminated from the body through the hepatobiliary system, which involves excretion through the liver and bile into the small intestine. A portion of the radiopharmaceutical may also be excreted through the urinary system. The excretion process helps to remove the radiopharmaceutical from the body over time.
Adminstartion
Administration:
The technetium Tc-99m sulfur colloid administration involves several steps to ensure proper imaging of the reticuloendothelial system (liver, spleen, and bone marrow). It’s important to note that the specific procedure may vary based on the imaging facility, the patient’s condition, and the equipment available.
Patient Preparation:
Before the procedure, inform the patient about the imaging process, its purpose, and any potential risks or discomfort.
Obtain a detailed medical history, including allergies, medications, and previous imaging studies.
Informed Consent:
Obtain informed consent from the patient, explaining the procedure, its purpose, potential risks, and benefits. Ensure the patient has an opportunity to ask questions and fully understands the process.
Fasting:
Depending on the imaging protocol and the organs of interest, the patient may be instructed to fast for a certain period before the procedure. Fasting helps enhance imaging quality by reducing interference from food in the digestive system.
Radiopharmaceutical Injection:
A radiopharmaceutical technologist or nurse will administer the Tc-99m sulfur colloid via intravenous (IV) injection. The radioactive tracer is introduced into the bloodstream.
The dosage is calculated depend on the patient’s weight, the specific imaging protocol, and the desired imaging quality.
Patient Resting Period:
After the injection, the patient is typically asked to rest quietly. This allows the radiopharmaceutical to circulate and accumulate in the reticuloendothelial system.
Imaging Procedure:
The patient is then positioned for imaging. Depending on the organs being studied (liver, spleen, bone marrow), the imaging equipment (gamma camera or SPECT scanner) will be positioned accordingly.
The imaging procedure involves the patient lying still on a table while the gamma camera or SPECT scanner captures images of the radiopharmaceutical distribution in the body.
Image Acquisition:
The imaging process may take some time, and the patient is asked to remain as still as possible. Multiple images are usually taken from different angles to create a comprehensive view.
Post-Imaging Care:
Once the imaging is complete, the patient can resume normal activities unless instructed otherwise by the healthcare provider.
Drinking fluids and emptying the bladder may help eliminate any remaining traces of the radiopharmaceutical from the body.
Image Interpretation:
A nuclear medicine physician will review and interpret the acquired images to assess the distribution and function of the reticuloendothelial system.
technetium Tc-99m sulfur colloid is a radiopharmaceutical commonly used in nuclear medicine imaging to visualize and assess the reticuloendothelial system. This system includes the liver, spleen, and bone marrow. Tc-99m sulfur colloid is administered intravenously, and its distribution in these organs is captured using gamma cameras or SPECT scanners.
Liver Imaging:
Tc-99m sulfur colloid can provide valuable information about the liver’s size, shape, and function. It is used to diagnose and monitor various liver conditions, including cirrhosis, hepatic lesions, and tumors. The distribution pattern of the radiopharmaceutical can help identify abnormalities within the liver.
Spleen Imaging:
Spleen imaging with Tc-99m sulfur colloid assesses spleen size, function, and blood flow. It can aid in diagnosing conditions such as splenomegaly (enlarged spleen), hypersplenism, and various spleen disorders.
Bone Marrow Imaging:
Tc-99m sulfur colloid can visualize bone marrow activity and distribution. It is beneficial in suspected bone marrow disorders, such as myeloproliferative disorders, bone marrow metastases, and certain hematologic malignancies.
Gastrointestinal Bleeding Detection:
Tc-99m sulfur colloid imaging can help locate the source of gastrointestinal bleeding. It is beneficial when bleeding is suspected but cannot be easily identified through other imaging techniques.
Sentinel Lymph Node Mapping:
In some instances of cancer, particularly breast cancer and melanoma, Tc-99m sulfur colloid can be used to identify sentinel lymph nodes. These are the first lymph nodes to which cancer cells are likely to spread. Mapping sentinel lymph nodes can help guide surgical decisions and staging.
Peritoneal Scintigraphy:
Tc-99m sulfur colloid can be used in peritoneal scintigraphy to assess fluid movement within the abdominal cavity. It may help diagnose conditions like peritoneal leaks or assess the effectiveness of peritoneal dialysis.
Reticuloendothelial System Function Evaluation:
Tc-99m sulfur colloid imaging can provide insights into the overall function of the reticuloendothelial system, a key role in immune responses and the removal of cellular debris.
Loading...
Free CME credits
Both our subscription plans include Free CME/CPD AMA PRA Category 1 credits.
Digital Certificate PDF
On course completion, you will receive a full-sized presentation quality digital certificate.
medtigo Simulation
A dynamic medical simulation platform designed to train healthcare professionals and students to effectively run code situations through an immersive hands-on experience in a live, interactive 3D environment.
medtigo Points
medtigo points is our unique point redemption system created to award users for interacting on our site. These points can be redeemed for special discounts on the medtigo marketplace as well as towards the membership cost itself.
Community Forum post/reply = 5 points
*Redemption of points can occur only through the medtigo marketplace, courses, or simulation system. Money will not be credited to your bank account. 10 points = $1.
All Your Certificates in One Place
When you have your licenses, certificates and CMEs in one place, it's easier to track your career growth. You can easily share these with hospitals as well, using your medtigo app.
